TME Pharma N : Inside Information / Other news releases -October 10, 2023 at 03:16 am EDT

TME PHARMA PROVIDES POSITIVE UPDATE ON 18-MONTH SURVIVAL FOR NOX-A12 COMBINATION REGIMEN IN BRAIN CANCER AND PROVIDES STRATEGIC UPDATE INCLUDING DECISION TO ENGAGE WITH US FDA

...

Related Keywords

United States ,Germany ,Spain ,France ,Paris ,France General ,Berlin ,Guillaume Van Renterghem ,Arthur Rouill ,Pharmanv Euronext ,Merck Keytruda ,Aram Mangasarian ,Merck Sharp Dohme Corp ,Pharma Press ,Drug Administration ,Euronext Growth Paris ,New England Journal ,Overall Survival ,Improve Survival ,Press Release ,New Drug ,Media Relations ,Merck Sharp ,Markets ,